Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,031.15 USD
-14.83 (-1.42%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $1,056.00 +24.85 (2.41%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | 11.72 |
EPS Last Quarter | 11.56 |
Last EPS Surprise | 9.37% |
ABR | 1.56 |
Earnings ESP
|
-13.46% |
---|---|
Current Year | 44.86 |
Next Year | 48.14 |
EPS (TTM) | 44.56 |
P/E (F1) | 23.32 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.67B | 3.82B | 14.18B | 15.27B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 3.83B | 4.03B | 14.55B | 15.86B |
Low Estimate | 3.55B | 3.63B | 13.94B | 14.61B |
Year ago Sales | 3.36B | 3.43B | 13.12B | 14.18B |
Year over Year Growth Est. | 9.16% | 11.11% | 8.13% | 7.63% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 11.72 | 11.63 | 44.86 | 48.14 |
# of Estimates | 10 | 8 | 12 | 11 |
Most Recent Consensus | 11.81 | 10.94 | 44.94 | 48.96 |
High Estimate | 13.29 | 13.49 | 48.00 | 56.60 |
Low Estimate | 10.14 | 9.53 | 41.75 | 41.16 |
Year ago EPS | 11.59 | 11.86 | 43.79 | 44.86 |
Year over Year Growth Est. | 1.12% | -1.94% | 2.44% | 7.29% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 3 | 9 | 8 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 5 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 11.72 | 11.63 | 44.86 | 48.14 |
7 Days Ago | 11.72 | 11.63 | 44.86 | 48.14 |
30 Days Ago | 11.72 | 11.63 | 44.86 | 48.14 |
60 Days Ago | 11.75 | 11.87 | 43.88 | 46.91 |
90 Days Ago | 11.87 | 11.97 | 43.77 | 46.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 10.14 | 11.63 | 41.75 | 44.20 |
Zacks Consensus Estimate | 11.72 | 11.63 | 44.86 | 48.14 |
Earnings ESP | -13.46% | 0.00% | -6.94% | -8.18% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 11.56 | 9.55 | 11.86 | 11.59 | NA |
Estimate | 10.57 | 10.20 | 10.43 | 10.80 | NA |
Difference | 0.99 | -0.65 | 1.43 | 0.79 | 0.64 |
Surprise | 9.37% | -6.37% | 13.71% | 7.31% | 6.01% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more